The Swiss Venous Thromboembolism Cohort 65+ (SWITCO65+)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this prospective multicenter cohort study is to examine long-term medical outcomes, quality of life, and medical resource utilization in elderly patients (>= 65 years) with acute venous thromboembolism (i.e., acute pulmonary embolism and/or deep vein thrombosis)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
65 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Outpatients and inpatients with acute venous thromboembolism from 9 Swiss university and non-university hospitals
Objectively confirmed acute pulmonary embolism and/or deep vein thrombosis
Age >=65 years
Thrombosis at a different site than lower limb
Insufficient spoken language ability in German or French
Follow-up not possible (e.g., terminally ill patients)
Informed consent not possible (e.g., severe dementia)